About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Bioconjugate Chemistry
›
Top Articles
Bioconjugate Chemistry
Pharmacology
,
Chemical Engineering
,
Chemistry
,
Biology
,
Biomedical Engineering
,
Biotechnology
,
Organic Chemistry
6.3
(top 2%)
Impact Factor
6.7
(top 2%)
extended IF
187
(top 1%)
H-Index
6.1K
authors
6.6K
papers
270.5K
citations
4.9K
citing journals
85.6K
citing authors
Most Cited Articles of Bioconjugate Chemistry
Title
Year
Citations
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains
2004
1.2K
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
1993
1K
Theranostics: combining imaging and therapy
2011
956
Noninvasive imaging of quantum dots in mice
2004
934
High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates
1999
787
Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects
2010
766
In vitro gene delivery by degraded polyamidoamine dendrimers
1996
735
Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters
1993
734
Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy
2005
623
Tetrazine-based cycloadditions: application to pretargeted live cell imaging
2008
584
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging
2012
561
Mechanism of amide formation by carbodiimide for bioconjugation in aqueous media
1995
554
Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs
2000
549
Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability
2006
547
Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C
2001
518
Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport
2004
508
pH-Responsive copolymer assemblies for controlled release of doxorubicin
2005
483
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
1992
482
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
2016
480
Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies
2010
470
Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system
2002
468
A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents
1992
468
"SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers
2006
461
1-(m-[211At]astatobenzyl)guanidine: synthesis via astato demetalation and preliminary in vitro and in vivo evaluation
1992
447
Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia
2002
440
previous
2013
2014
2015
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.